Filter
346
Featured
Recommendations
13
New Publications
33
Language
Document type
No document type
121
Guidelines
116
Studies & Reports
62
Fact sheets
22
Infographics
9
Manuals
5
Situation Updates
3
Training Material
2
Resource Platforms
2
Strategic & Response Plan
2
Brochures
1
Online Courses
1
Countries / Regions
Malawi
8
South Africa
7
Latin America and the Carribbean
7
Global
6
East and Southern Africa
5
Africa
5
Uganda
4
South–East Asia Region
3
Western and Central Europe
3
Asia
3
USA
2
Zambia
2
Kenya
2
Lesotho
2
Congo, Democratic Republic of
1
Guinea-Bissau
1
Zimbabwe
1
Philippines
1
India
1
Nepal
1
Pakistan
1
Afghanistan
1
Syria
1
Cambodia
1
Bangladesh
1
Mozambique
1
Brazil
1
El Salvador
1
Angola
1
Sri Lanka
1
Yemen
1
Middle East and North Africa
1
Western Pacific Region
1
Bhutan
1
Laos
1
Russia
1
Vietnam
1
North America
1
Jamaica
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
53
Countries
29
Women & Child Health
7
Pharmacy & Technologies
3
Public Health
2
Capacity Building
1
Key Resources
1
Technical Report
AIDS Medicines and diagnostics service
July 2015
Technical Report
AIDS Medicines and diagnostics service
July 2015
Supplement Article
WHO Guidelines for HIV PEP • CID 2015:60 (Suppl 3), S161 - S164
This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing thirty key questions about PrEP and how it might be implemented in the UK.
Supplement Article
Antiretrovirals to Prevent HIV Infection • CID 2015:60 (Suppl 3) • S159 - S160
Pre-exposure prophylaxis (PrEP)
Policy Brief
November 2015
Technical report
February 2015
Public Report
PQMC 0003-003-00 WHO PQMC PR June/2015, version 2.0
Guidelines
HIV testing services
July 2015
Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest daily management problems faced by health care workers caring for patients with HIV infection
Contraceptive Dynamics Following HIV Testing
Compendium of Case Studies
2014
Addendum to meeting report: Regional consultation on HIV epidemiologic information in Latin America and the Caribbean
Providing expert scientific advice on HIV
EAGA Secretariat
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re
...
Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents, and children: recommendations for a public health approach : December 2014 supplement to the 2013 Consolidated guidelines on the use of antiretroviral drugs
...
